1-3 of 3
Olga Meltem Akay
Close
Sort by
Journal Articles

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Burhan Ferhanoglu, Zafer Gulbas, Ant Uzay, Muhit Özcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Asu Fergun Yilmaz, Derya Koyun, Nihan Alkis, Elif Birtas Atesoglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 6704–6705.
https://doi.org/10.1182/blood-2022-165385
Published: 2022
Journal Articles

An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Omur Gokmen Sevindik, Zubeyde Nur Ozkurt, Can Boga, Sevgi Kalayoglu Besisik, Yildiz Ipek, Ayfer Geduk, Aybuke Harmandali, Ayse Salihoglu, Handan haydaroglu Sahin, Mehmet Sönmez, Filiz Vural, Olga Meltem Akay, Meltem Kurt Yuksel, Senem Maral, Omer Ekinci, Onur Hakki Kirkizlar, Atakan Tekinalp, Nazli Demir, Mustafa Merter, Guray Saydam, İnci Alacacıoğlu, Zeynep Arzu Yegin, Mutlu Kasar, Metban Mastanzade, Guner Hayri Ozsan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2021-150175
Published: 2021
Journal Articles

Safety and Efficacy of Activated Recombinant FVII in Uncontrolled Bleeding Episodes.

Eren Gunduz, Olga Meltem Akay, Hava Uskudar Teke, Zafer Gulbas
Journal: Blood
Blood (2006) 108 (11): 4078.
https://doi.org/10.1182/blood.V108.11.4078.4078
Published: 2006